Key Takeaways & Executive Findings
- •• EMB1006 specifically binds to a sequence near the 3' end of clpP1 exon 2, guided by PPR code prediction. • EMB1006 forms a protein complex with EMB1270, EMB976, and CFM2, as revealed by immunoprecipitation and mass spectrometry. • Direct interactions between EMB1006 and EMB1270 or CFM2 are confirmed by yeast two-hybrid and pull-down assays, while EMB976 associates indirectly. • A model is proposed where EMB1006 and EMB1270 bind distinct sites on clpP1 pre-mRNA, assembling with CFM2 and EMB976 to facilitate clpP1 intron 2 splicing in chloroplasts.
Abstract
In Arabidopsis, the PPR proteins EMB1006, EMB1270, and EMB976 are all essential for the splicing of plastid clpP1 intron 2 (clpP1.2), although each also targets other distinct RNAs. The precise mechanism underlying their co-ordinated action in clpP1.2 splicing remains unclear. In this study, RNA electrophoretic mobility shift assays, guided by PPR code prediction, confirm that EMB1006 specifically binds to a sequence near the 3′ end of clpP1 exon 2. Additionally, immunoprecipitation coupled with mass spectrometry reveals that EMB1006 forms a complex with EMB1270, EMB976, and CFM2. Direct interactions between EMB1006 and EMB1270 or CFM2 are further supported by yeast two-hybrid (Y2H) and semi-in vivo pull-down assays. However, no direct interactions between EMB976 and EMB1006, CFM2 or EMB1270 are detected by Y2H. Based on these findings and previous evidence that EMB1270 binds to clpP1 intron 2 and interacts with CFM2, we propose a model in which EMB1006 and EMB1270 bind to distinct sites on clpP1 pre-mRNA. Together with CFM2 and possible indirect association with EMB976, they assemble into a protein-RNA complex that facilitates the splicing of clpP1.2 in chloroplasts.
1. Introduction
Plastids and mitochondria are semi-autonomous organelles whose gene expression is tightly regulated by a multitude of nucleus-encoded proteins [1]. Among these regulators, pentatricopeptide repeat (PPR) proteins constitute the largest family involved in post-transcriptional regulation within the organelles of higher plants. These proteins are characterized by tandem repeats of an ~35-amino-acid motif, with each protein containing 2–30 such repeats. Based on the features of these PPR motifs, the family is divided into P and PLS subfamilies [2]. A key characteristic of PPR proteins is their ability to bind to specific RNA sequences through a “one-repeat-to-one-nucleotide” recognition mechanism. It is well established that they play diverse roles in organellar RNA processing. Generally, P-type PPRs are implicated in RNA stabilization, cleavage, and intron splicing, whereas PLS-type members primarily participate in RNA editing [3].
In the Arabidopsis plastid genome, the twenty introns are categorized into group I (represented by a single intron) and group II (comprising 19 introns) based on their splicing mechanisms [4,5]. Since group II introns have entirely lost the capacity for self-splicing, their removal depends on numerous nucleus-encoded factors. Beyond PPR proteins, other RNA-binding proteins are also crucial for group II intron splicing. These include chloroplast RNA splicing 1 (CRS1), CRS2-associated factors (CAF1 and CAF2) [6], and chloroplast RNA splicing and ribosome maturation (CRM) family members (CFM1, CFM2, and CFM3) [7–9]. Notably, many of these proteins, such as CRS1, CAF1, CAF2, CFM1, CFM2, and CFM3, share a conserved CRM domain. Furthermore, RNC1, a ribonuclease III domain protein initially identified in maize chloroplasts as part of CAF1/CAF2 complexes, is required for the splicing of several group II introns [10]. Another key factor is WTF1 (What’s This Factor 1), which contains an RNA-binding DUF860 domain and interacts with RNC1 to promote the splicing of multiple group II introns [11]. Given that mutations in RNC1 and WTF1 disrupt the splicing of most plastid introns, they are considered general splicing factors. In contrast, PPR proteins are hypothesized to act earlier by conferring sequence specificity. They are thought to initiate splicing by binding to specific RNA sequences and altering the RNA structure, thereby facilitating the recruitment of general splicing complexes such as those containing WTF1/RNC1 or CRM proteins [1]. This functional model is supported by recent studies in both mitochondria and chloroplasts. For instance, in Arabidopsis chloroplasts, the PPR protein EMB1270 interacts with the CRM-domain protein CFM2 to promote the splicing of specific group II introns [5]. Similarly, in maize mitochondria, the PPR protein PPR14, which functions through physical interactions with PPR-SMR1 and the CRM protein Zm-mCSF1, is essential for the splicing of mitochondrial nad2 intron 3 and nad7 introns 1 and 2 [12]. Furthermore, Small PPR Protein 2 (SPR2), which contains only four PPR repeats, participates in the splicing of over half of the introns in maize mitochondria by interacting with the small MutS-related domain protein PPR-SMR1. Both SPR2 and PPR-SMR1 can also interact with additional splicing factors, including the PPR proteins EMPTY PERICARP16 and PPR14, as well as the CRM protein Zm-mCSF1, which are involved in the splicing of specific introns [13].
The caseinolytic protease (Clp) is essential for plastid development and function, primarily by degrading misfolded, aggregated, or otherwise unwanted proteins [14]. The Clp system comprises a tetradecameric proteolytic core—composed of catalytic...
Loading authentic research manuscript (Pages 1–5)...
Liqun Zhang, Fangsheng Liao, Ying Wei, Keyi Yang, Yawen Zhu, Li Zhang, Wenyujie Shi, Shuya Zhou, Jirong Huang, Yong-Lan Cui, Weihua Huang (2026). A protein-RNA complex orchestrated by EMB1006, EMB1270, EMB976, and CFM2 facilitates clpP1 intron 2 splicing in Arabidopsis chloroplasts. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2026076
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the role of EMB1006 in clpP1 intron 2 splicing?
EMB1006 specifically binds to a sequence near the 3' end of clpP1 exon 2, as confirmed by RNA electrophoretic mobility shift assays guided by PPR code prediction. It forms a complex with EMB1270, EMB976, and CFM2 to facilitate the splicing of clpP1 intron 2 in Arabidopsis chloroplasts.
How do EMB1006, EMB1270, EMB976, and CFM2 interact?
Immunoprecipitation and mass spectrometry reveal that EMB1006 forms a complex with EMB1270, EMB976, and CFM2. Direct interactions between EMB1006 and EMB1270 or CFM2 are supported by yeast two-hybrid and pull-down assays, while EMB976 associates indirectly with the complex.
What is the proposed model for clpP1 intron 2 splicing?
The proposed model suggests that EMB1006 and EMB1270 bind to distinct sites on clpP1 pre-mRNA. Together with CFM2 and possible indirect association with EMB976, they assemble into a protein-RNA complex that facilitates the splicing of clpP1.2 in chloroplasts.
Why is the splicing of clpP1 intron 2 important?
The clpP1 gene encodes a catalytic subunit of the caseinolytic protease (Clp) complex, which is essential for plastid development and function by degrading misfolded or unwanted proteins. Proper splicing of clpP1 intron 2 is crucial for the production of functional ClpP1 and thus for chloroplast biogenesis.
What techniques were used to study the protein-RNA interactions?
The study employed RNA electrophoretic mobility shift assays (REMSA), immunoprecipitation coupled with mass spectrometry (IP-MS), yeast two-hybrid (Y2H) assays, and semi-in vivo pull-down assays to investigate the interactions and binding sites.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.